AVID Medical recalls epidural trays in Class I action over saline ampules

AVID Medical is recalling pre-packed epidural trays not because of anything the company made, but because of a small part tucked inside them: a saline ampule caught in a separate recall. The Food and Drug Administration logged the action in its enforcement database on 23 September 2026 and classified it as Class I — the agency's most serious recall tier, used where a defect could cause serious injury or death [s1].

What is affected

The recall covers the Haylard 18G Single Shot Epi Tray, model DPGE002-02, with 1,640 kits in the affected quantity, distributed to four states: Illinois, North Carolina, Virginia and Wyoming [s1]. Four kit lots are named — 1641713, 1641714, 1659697 and 1668209 — and the record identifies the specific component at issue as recalled sodium-chloride ampule lot AB4003 [s1]. AVID Medical, based in Toano, Virginia, began the recall itself on 10 August 2026, a voluntary, firm-initiated action, and the FDA lists its status as ongoing [s1].

Why a single ampule triggers a tray recall

The reason stated is the "potential for product quality and sterility issues regarding kits containing Sodium Chloride ampules subject to recall by Spectra Medical" [s1]. The ampules are the trigger. In a companion Class I action logged on 19 August 2026, Spectra Medical Devices recalled its Sodium Chloride Injection, 0.9% USP, 10 mL ampule — a saline flush used within convenience kits — after its manufacturing firm, Huons, was cited for issues with product quality and sterility assurance [s2]. That record spells out the hazard: if the product's sterility is compromised, "patients may be exposed to microorganisms, endotoxins, or foreign matter," which "may trigger inflammatory responses, infections, micro-clots, and organ failure" [s2]. The recalled ampule lot AB4003 named in AVID's tray recall appears among the lots Spectra withdrew [s2].

Because the ampule carries no individual barcode — it is used only inside kits — the recall has to reach patients through the trays that contain it [s2]. AVID's action is the downstream half of that chain: the ampule was packed into sealed epidural trays, so the whole tray is pulled rather than a loose vial [s1].

The wider context

A single-shot epidural tray gathers in one sterile package the items a clinician needs to place a regional anaesthetic — commonly for labour pain or for anaesthesia during a procedure. Saline is a routine part of that set, used to confirm needle placement and to flush. The episode is a case study in how modern medical supply works: a sterility problem at a contract manufacturer flows into a saline ampule, into a kit packer's tray, and out to hospitals in several states, each handoff widening the recall. It also shows why kit packers such as AVID issue their own recalls even when the fault originated elsewhere — the sealed tray is the unit a clinician actually opens [s1][s2].

The limited distribution is some comfort and no guarantee. AVID's trays went to four states, and the component — a 10 mL saline ampule with no barcode of its own — can only be traced through the kits that carry it, which is why the recall is written around tray lot numbers rather than vials [s1][s2]. The Spectra action named a long run of ampule lots, from AB3005 through AB5008, so the AB4003 lot flagged in AVID's trays is one thread of a broader withdrawal that touched kit packers in six states [s2].

What to do

This action is directed at hospitals and the anaesthesia and obstetric teams who open these trays, not at consumers; the epidural tray is a professional procedure kit [s1]. A Class I recall sets a clear task: identify whether any of the named kit lots — 1641713, 1641714, 1659697 or 1668209 — are in stock, quarantine them, and follow AVID Medical's instructions for return or replacement before use [s1].

Red flags that belong with a care team rather than a shelf check include signs of infection after a recent epidural or spinal procedure — fever, worsening back pain at the injection site, spreading redness, or new neurological symptoms [s2]. Those warrant prompt medical assessment on their own. The recall records describe a sterility hazard and its potential consequences, not any count of patients harmed [s1][s2].

This article describes two FDA enforcement actions and is not medical advice. Anyone concerned about a recent epidural or spinal procedure should speak to the treating clinicians, who can judge symptoms directly and check whether affected lots were involved.

Sources

• FDA Enforcement Report Z-3151-2026: AVID Medical Haylard 18G Single Shot Epi Tray, DPGE002-02 — U.S. Food and Drug Administration, report date 23 September 2026
• FDA Enforcement Report Z-2873-2026: Spectra Medical Devices Sodium Chloride Injection 0.9% USP 10 mL ampule — U.S. Food and Drug Administration, report date 19 August 2026